Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPrediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
Cancer Epidemiology, Biomarkers & Prevention, 11/06/09
Ahn J et al. – The findings suggest that prior observations regarding serum total cholesterol and cancer are largely explained by reverse causation. Although chance and reverse causation may explain some of the inverse HDL associations, we cannot rule out some etiologic role for this lipid fraction.
Related Articles
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis
Arthritis & Rheumatism, 10/01/09
Relevance Score: 90%
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Vascular Health and Risk Management, 11/03/09
Relevance Score: 88%
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Vascular Health and Risk Management, 11/03/09
Relevance Score: 88%
Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study
Atherosclerosis, 10/07/09
Relevance Score: 88%
Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks
Diabetic Medicine, 10/05/09
Relevance Score: 88%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes
Journal of Hypertension, 11/25/09
The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease
Medicine, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor